IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 1286 
Small font sizeDefault font sizeIncrease font size
Navigate Here
 »   Next article
 »   Previous article
 »   Table of Contents

Resource Links
 »   Similar in PUBMED
 »  Search Pubmed for
 »  Search in Google Scholar for
 »Related articles
 »   Citation Manager
 »   Access Statistics
 »   Reader Comments
 »   Email Alert *
 »   Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded213    
    Comments [Add]    

Recommend this journal


Year : 2000  |  Volume : 32  |  Issue : 5  |  Page : 256-268

Cancer chemotherapy and radiation induced emesis (CRIE): current and future therapeutic approaches

Correspondence Address:
A Abraham

Login to access the Email id

Source of Support: None, Conflict of Interest: None

Rights and PermissionsRights and Permissions

Nausea and vomiting caused by radiation and chemotherapy in cancer patients often tends to be more traumatic than the disease itself. Classical anti-emetic agents have offered very little protection against cancer chemotherapy and radiation induced emesis (CRIE). Newer agents that have immense potential and efficacy to treat this type of emesis are the 5-HT3 antagonists and NK1 antagonists. The high cost of 5-HT3 antagonists calls for the use of prudent combination regimens so as to have cost-effective management of emesis in cancer patients. Delayed emesis, a problem often witnessed in CRIE cannot be managed by the administration of serotonergic antagonists alone. Hence a cost-effective combination regimen which includes classical anti-emetic drugs may perhaps find an important place in future therapeutic approaches. This review highlights the various aspects associated with CRIE, including its physiology and newer therapeutic agents available to treat CRIE.


Print this article     Email this article

Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer | Privacy Notice
Online since 20th July '04
Published by Wolters Kluwer - Medknow